Bristol-Myers Squibb bms.com

Bristol-Myers Squibb (NYSE: BMY) is a global biopharmaceutical company committed to discovering, developing, and delivering medicines that help patients prevail over serious diseases.

Bristol-Myers Squibb (NYSE: BMY) is a global biopharmaceutical company committed to discovering, developing, and delivering medicines that help patients prevail over serious diseases.

See All Exits Recent Exits

Phone: 800-332-2056

Fax:

430 E. 29th Street
14th Floor
 New York, 10016
 New York, United States

Bristol-Myers Squibb - Investments & Acquisitions

Show Real Data Bristol-Myers Squibb Investments
See all Recent Investments
Date Company Round Amount Co-investors
2021-05-19HiberCellSeries B$67.4MARCH Venture Partners, Hercules Capital, Huizenga Capital Management, Magnetic Ventures, Monashee Investment Management, Mount Sinai Innovation Partners, Tekla Capital Management, and Trinitas Capital
2021-05-18PathAISeries C$165M8VC, Adage Capital Management, Biospring Partners, D1 Capital Partners, General Atlantic, General Catalyst, Kaiser Permanente Ventures, KdT Ventures, LabCorp Venture Fund, Merck Global Health Innovation Fund, Polaris Partners, Refactor Capital, and Tiger Global Management
2021-04-27ExscientiaSeries D$225MBlackRock, Casdin Capital, Farallon Capital Management, GT Healthcare Capital Partners, Hongkou Capital, Laurion Capital Management, Marshall Wace Asset Management, Mubadala Investment Company, Novo Holdings, Pivotal bioVenture Partners, and SoftBank Group
2021-03-18Aktis OncologySeries A$72MEcoR1 Capital, MPM Capital, Novartis, Octagon Capital, The Column Group, and Vida Ventures
2021-03-04ExscientiaSeries C - II$40MBlackRock, Evotec, GT Healthcare Capital Partners, and Novo Holdings
See all 5 investments